Miromatrix Reports Third Quarter 2023 Results
November 14, 2023 16:05 ET
|
Miromatrix Medical Inc.
EDEN PRAIRIE, Minn., Nov. 14, 2023 (GLOBE NEWSWIRE) -- Miromatrix Medical Inc. (Nasdaq: MIRO) (the “Company”), a life sciences company pioneering a novel technology for bioengineering fully...
United Therapeutics to Acquire Miromatrix Medical
October 30, 2023 06:05 ET
|
Miromatrix Medical Inc.
SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C. and EDEN PRAIRIE, Minn., Oct. 30, 2023 (GLOBE NEWSWIRE) -- United Therapeutics Corporation (Nasdaq: UTHR) and Miromatrix Medical Inc. (Nasdaq:...
Miromatrix to Present at the 2023 ISODP Organ Donation Congress
October 11, 2023 16:05 ET
|
Miromatrix Medical Inc.
EDEN PRAIRIE, Minn., Oct. 11, 2023 (GLOBE NEWSWIRE) -- Miromatrix Medical Inc. (NASDAQ: MIRO), a life sciences company pioneering a novel technology for bioengineering fully transplantable organs to...
Miromatrix CEO Jeff Ross to Present at the 2023 Cell & Gene Meeting on the Mesa
October 05, 2023 16:30 ET
|
Miromatrix Medical Inc.
EDEN PRAIRIE, Minn., Oct. 05, 2023 (GLOBE NEWSWIRE) -- Miromatrix Medical Inc. (NASDAQ: MIRO), a life sciences company pioneering a novel technology for bioengineering fully transplantable organs to...
Miromatrix Announces Participation in H.C. Wainwright Global Investment Conference
September 06, 2023 16:01 ET
|
Miromatrix Medical Inc.
EDEN PRAIRIE, Minn., Sept. 06, 2023 (GLOBE NEWSWIRE) -- Miromatrix Medical Inc. (NASDAQ: MIRO), a life sciences company pioneering a novel technology for bioengineering fully transplantable organs...
Miromatrix Announces Participation in the ARM Tissue Engineering and Therapeutics Workshop
September 05, 2023 16:04 ET
|
Miromatrix Medical Inc.
EDEN PRAIRIE, Minn., Sept. 05, 2023 (GLOBE NEWSWIRE) -- Miromatrix Medical Inc. (NASDAQ: MIRO), a life sciences company pioneering a novel technology for bioengineering fully transplantable organs...
Miromatrix Reports Second Quarter 2023 Results and Provides Corporate Update
August 14, 2023 16:01 ET
|
Miromatrix Medical Inc.
EDEN PRAIRIE, Minn., Aug. 14, 2023 (GLOBE NEWSWIRE) -- Miromatrix Medical Inc. (NASDAQ: MIRO), a life sciences company pioneering a novel technology for bioengineering fully transplantable organs...
Miromatrix to Report Second Quarter 2023 Financial Results
July 25, 2023 16:01 ET
|
Miromatrix Medical Inc.
EDEN PRAIRIE, Minn., July 25, 2023 (GLOBE NEWSWIRE) -- Miromatrix Medical Inc. (NASDAQ: MIRO), a life sciences company pioneering a novel technology for bioengineering fully transplantable organs to...
Miromatrix Poster Voted Best in Congress at the 2023 American Transplant Congress; Jack Lake Wins Lifetime Achievement Award
July 13, 2023 16:01 ET
|
Miromatrix Medical Inc.
EDEN PRAIRIE, Minn., July 13, 2023 (GLOBE NEWSWIRE) -- Miromatrix Medical Inc. (NASDAQ: MIRO), a life sciences company pioneering a novel technology for bioengineering fully transplantable organs to...
Miromatrix Announces CEO Jeff Ross, Ph.D. will Expand His Role by Resuming Leadership of R&D
June 01, 2023 16:01 ET
|
Miromatrix Medical Inc.
EDEN PRAIRIE, Minn., June 01, 2023 (GLOBE NEWSWIRE) -- Miromatrix Medical Inc. (NASDAQ: MIRO), a life sciences company pioneering a novel technology for bioengineering fully transplantable organs to...